ideasIdea
Ring-fence a fifth of national cancer research money for metastasis
Spread causes around nine in ten cancer deaths but receives a small slice of research funding. A funding floor would change what gets studied.
Portfolio analyses have repeatedly put metastasis research at roughly 5-10% of cancer research spend. A committed floor — with a transparent classification method, an annual public report and a dedicated review panel that understands metastasis models — is a pure policy lever with no scientific risk, only allocation risk.
Hypothesis
A ring-fenced metastasis programme with its own review panel doubles the number of funded metastasis-specific projects within three years and measurably increases metastasis-focused clinical trials within eight.
Rationale
Dedicated funding streams reliably grow fields: the same mechanism built radiopharmaceuticals, immunotherapy and paediatric oncology networks. Metastasis loses in general competition because its models are slower and its endpoints harder, which is a review-dynamics problem rather than a merit problem.
What would test it
One funder pilots a ring-fenced call with pre-registered classification of awards, then compares downstream publications, trials and career retention against matched general-competition awards over five years.
Maturity
speculative
Who has to act
policy
Cost to try
Small (under $1M)
Years to first evidence
8
Bottlenecks it attacks
- Metastasis is understood least and studied last · Metastasis causes about nine in ten cancer deaths but gets a small fraction of research money and almost no trials of its own.
- Funding follows fashion, not burden · Money goes to the cancers and questions that are easy or popular, not the ones that kill most or where a dollar would do most.